In this study, we showed for the first time that the promising anticarcinogenic flavonoid Luteolin (LUT) decreased AKT/mTOR signaling and in parallel induced caspase-dependent cell death in both primary and metastatic cutaneous squamous cell carcinoma (SCC) cells. The gene discussed is AKT1; the disease is cutaneous squamous cell carcinoma.